SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?


To: luckydog88 who wrote (63012)2/13/2025 10:04:32 PM
From: stockdoc772 Recommendations

Recommended By
erippetoe
rodneyh07

  Respond to of 63305
 
Over the last five years quarterly revenues have risen from 100 million to 700 million and the stock price is stuck in the low 100s. Go figure. The Wainwright analyst basically claimed that most DMD patients will not choose to get the gene therapy. I guess they would rather die in his estimation.